AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    4,718.00p (mid)

  • Current Change (%)

    0.12%

  • Price

    Bid: 4,717.50p

    Offer: 4,718.50p

  • Today

    High: 4,747.50p

    Low: 4,705.75p

  • This year

    High: 5,508.00p

    Low: 4,325.00p

  • Information

    Volume: 459,171

    Market Cap: £59736.21M


AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
AstraZeneca's IMFINZI approved for Stage III nsclc 07:00 - February 19, 2018
Selumetinib in NF1 gets FDA orphan drug status 07:00 - February 15, 2018
Director/PDMR Shareholding 14:00 - February 5, 2018
AZN: Full-Year 2017 Results 07:00 - February 2, 2018
Total Voting Rights 15:00 - February 1, 2018
AZ Reports Phase III Results for PT010 in COPD 18:20 - January 26, 2018
AZ Reports Phase III Results for PT010 in COPD 07:00 - January 26, 2018
LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER 07:00 - January 19, 2018
ASTRAZENECA'S FASENRA RECEIVES APPROVAL IN JAPAN 07:00 - January 19, 2018
FDA approves Lynparza for metastatic breast cancer 16:10 - January 12, 2018
FDA approves Lynparza for metastatic breast cancer 16:10 - January 12, 2018
FDA approves Lynparza for metastatic breast cancer 16:10 - January 12, 2018
FDA approves Lynparza for metastatic breast cancer 16:10 - January 12, 2018
AstraZeneca's Fasenra approved in the EU 15:10 - January 10, 2018
AstraZeneca's Fasenra approved in the EU 15:10 - January 10, 2018

NOTE: This is based on 310 open tips for this company


Total Number of Share tips :

310

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today